📌 HORIZON-EIC-2024-PATHFINDERCHALLENGES-01-02

 

Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer

Description: This EIC Pathfinder Challenge aims to support early-stage, high-risk research projects that develop autonomous agents powered by Generative AI to improve cancer diagnosis and treatment.

💰 Budget: €3M to €4M | ⏳ Duration: Typically 36 to 48 months (3 to 4 years)| 📅 Deadline: October 29, 2025

 
 

Short Idea:

Developing generative AI agents that integrate multimodal medical data to support clinicians with early diagnosis and personalized cancer treatment pathways.

 

Abstract

This project proposes the development of intelligent autonomous agents based on Generative AI to transform cancer diagnosis and treatment. By integrating diverse health data — including imaging, genomics, and clinical records — these agents will offer predictive diagnostics and personalized therapy selection. The solution will be tested for interpretability, data security, and ethical compliance. Ultimately, the project aims to contribute advanced AI tools and synthetic datasets to the Cancer Image Europe platform and establish a benchmark for regulatory-ready medical AI in Europe.

Who’s Behind?

🔥 Key Partners

Mugenbio

Country: Switzerland

Organization Scope: Deeptech startup

Role in the Project: Project coordination

European Institute of Oncology

Country: Italy

Organization Scope: Leading cancer research

Role in the Project: Provide real-world clinical data 

Fraunhofer MEVIS

Country: Germany

Organization Scope: Medical Imaging Research Institute

Role in the Project: Develop explainable AI components

Pending

Country: Spain

Organization Scope: National Supercomputing 

Role in the Project: Provide high-performance computing infrastructure

Interested? Apply Now